Lateral Flow Assays Market Analysis

End Users (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies)

The diagnostic laboratory segment is estimated to hold the largest share of the lateral flow assays market during the time period between 2025-2037. The growth of the segment is driven by increased demand for flow analysis testing. Moreover, for any viral spread of infections, lateral flow tests are used by various institutions and governments to confirm symptomatic and asymptomatic infections.

Product (Kits & Reagents, Lateral Flow Readers)

Lateral flow assays (LFA) market from the kits and reagents segment is set to occupy a noteworthy gain of 60% by the end of 2037. The growth of this segment is driven by the growing demand for rapid anti-care tests. These products are widely used in different environments, such as clinics, hospitals, and home testing, due to their simplicity, ease of use, and anti-fast turnaround times. The growth of new innovative anti-horizontal scanning technologies, such as smartphone-based anti-flow digital scanning, is also driving demand for kits and reagents.

Our in-depth analysis of the global lateral flow assays (LFA) market includes the following segments:

Product	Kits & Reagents Lateral Flow Readers
End Users	Hospitals Diagnostic Laboratories Pharmaceutical Companies

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lateral flow assays is estimated at USD 13.53 billion.

The lateral flow assays market size was valued at USD 12.76 billion in 2024 and is expected to cross USD 32.52 billion by the end of 2037, registering more than 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of infectious diseases and spiking healthcare spending will propel the market growth.

North America industry is assumed to hold a notable share of 26% by 2037, driving the development of new and innovative transverse flow analysis technologies in the region.

The major players in the market include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kGaA, PerkinElmer Inc.

Lateral Flow Assays Market Analysis